# XORTX Therapeutics Inc.: Form 6-K, filed May 16, 2025

- Company: [XORTX Therapeutics Inc.](/companies/xrtx.md) (CIK 1729214)
- Form: 6-K
- Filed: 2025-05-16
- Accepted by EDGAR: May 16, 2025, 11:50 ET
- Period: 2025-03-31
- Accession: 0001171843-25-003273
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1729214/000117184325003273/f6k_051625.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1729214/000117184325003273/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1729214/000117184325003273/f6k_051625.htm

Filed May 16, 2025.
Source: SEC EDGAR, the filing index for accession 0001171843-25-003273. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.